No abstract available
MeSH terms
-
Adenocarcinoma / enzymology
-
Adenocarcinoma / pathology
-
Adenocarcinoma / therapy*
-
Adenocarcinoma of Lung
-
Anaplastic Lymphoma Kinase
-
Angiogenesis Inhibitors / therapeutic use
-
Bevacizumab / therapeutic use*
-
Biomarkers, Tumor / metabolism
-
Brain Neoplasms / diagnosis
-
Brain Neoplasms / secondary
-
Brain Neoplasms / therapy*
-
Female
-
Follow-Up Studies
-
Humans
-
Lung Neoplasms / enzymology
-
Lung Neoplasms / pathology
-
Lung Neoplasms / therapy*
-
Magnetic Resonance Imaging
-
Middle Aged
-
Radiotherapy, Adjuvant
-
Receptor Protein-Tyrosine Kinases / metabolism*
-
Tomography, X-Ray Computed
Substances
-
Angiogenesis Inhibitors
-
Biomarkers, Tumor
-
Bevacizumab
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases